Research at St. Michael’s Hospital is a world centre of diabetes research with a program that spans the full breadth of discovery medicine from molecular analyses, through cell biology and animal studies, on to clinical trials, epidemiology and education research. 

With landmark papers in the leading medical and scientific journals, pivotal roles in developing treatment guidelines and attracting the best investigators from around the world, our program is poised to continue its upward trajectory in ground-breaking research to help our patients.

Dr. Gilbert lab (High Res) v1



Featured Publications

  • Zhang Y, Yuen DA, Advani A, Thai K, Advani SL, Kepecs D, Kabir MG, Connelly KA, Gilbert RE.  Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes.  Diabetes 2012, Aug;61(8):2114-25
  • Gilbert RE, Zhang Y, Williams SJ, Zammit SC, Stapleton DI, Cox AJ, Krum H, Langham R, Kelly DJ.  A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat.  PLoS One. 2012;7(10):e47160
  • Yuen DA, Zhang Y, Thai K, Spring C, Chan L, Guo X, Advani A, Sivak JM, Gilbert RE.  Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation.  Stem Cells Transl Med 2012; 921-926.
  • Connelly KA, Advani A, Advani S, Zhang Y, Thai K, Thomas S, Krum H, Kelly DJ, Gilbert RE.  Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.  Cardiovasc Ther. 2013 Apr;31(2):84-91.
  • Kosanam H, Thai K, Zhang Y, Advani A, Connelly KA, Diamandis EP and Gilbert RE.  Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidney. Diabetes 2014 Jul;63(7):2432-9.
  • Connelly KA, Advani A, Advani SL, Zhang Y, Kim YM, Shen V, Thai K, Kelly DJ, Gilbert RE.  Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.  Acta Diabetol 2014 Oct;51(5):771-82
  • Gilbert RE, Mann JF, Hanefeld M, Spinas G, Bosch J, Yusuf S, Gerstein HC and the ORIGIN trial investigators.  Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.  Diabetologia 2014 Jul;57(7):1325-31
  • Gilbert RE, Thai K, Advani SL, Cummins CL, Kepecs DM, Schroer SA, Woo M, Zhang Y. Sirt1 activation ameliorates hyperglycaemia by inducing a torpor-like state in obese type 2 diabetic mice. Diabetologia 2015 Apr;58(4):819-27
  • Gilbert RE, Krum H. Heart Failure in Diabetes: Effects of Anti-Hyperglycaemic Drug Therapy. Lancet. 2015 May 23;385(9982):2107-17.
  • Leiter LA, Forst T, Polidori D, Balis DA, Xie J, Sha S. Effect of canagliflozin on liver function tests in patients with type 2 diabetes. Diabetes Metab. 2015 Nov 10. pii: S1262-3636(15)00125-1.
  • Jenkins DJ, Jones PJ, Frohlich J, Lamarche B, Ireland C, Nishi SK, Srichaikul K, Galange P, Pellini C, Faulkner D, de Souza RJ, Sievenpiper JL, Mirrahimi A, Jayalath VH, Augustin LS, Bashyam B, Leiter LA, Josse R, Couture P, Ramprasath V, Kendall CW. The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. Nutr Metab Cardiovasc Dis. 2015 Nov 6. pii: S0939-4753(15)30010-7. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
  • Cavender MA, Scirica BM, Raz I, Steg PG, McGuire DK, Leiter LA, Hirshberg B, Davidson J, Cahn A, Mosenzon O, Im K, Braunwald E, Bhatt DL. Am J Med. 2015 Oct 30. pii: S0002-9343(15)01017-7.
  • Leiter LA, Teoh H, Mosenzon O, Cahn A, Hirshberg B, Stahre CA, Hoekstra JB, Alvarsson M, Im K, Scirica BM, Bhatt DL, Raz I; SAVOR-TIMI 53 Steering Committee, Investigators. Frequency of Cancer Events with Saxagliptin in the SAVOR-TIMI 53 Trial. Diabetes Obes Metab. 2015 Oct 7.
  • Wang JY, Goodman SG, Saltzman I, Wong GC, Huynh T, Dery JP, Leiter LA, Bhatt DL, Welsh RC, Spencer FA, Fox KA, Yan AT; Global Registry of Acute Coronary Events (GRACE/GRACE-2); Canadian Registry of Acute Coronary Events (CANRACE) Investigators. Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events. Can J Cardiol. 2015 Dec;31(12):1455-61.
  • Cefalu WT, Leiter LA, de Bruin TW, Gause-Nilsson I, Sugg J, Parikh SJ. Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension. Diabetes Care. 2015 Jul;38(7):1218-27.
  • Papaioannou A, Santesso N, Morin SN, Feldman S, Adachi JD, Crilly R, Giangregorio LM, Jaglal S, Josse RG, Kaasalainen S, Katz P, Moser A, Pickard L, Weiler H, Whiting S, Skidmore CJ, Cheung AM; Scientific Advisory Council of Osteoporosis Canada. Recommendations for preventing fracture in long-term care. CMAJ. 2015 Oct 20;187(15):1135-44.
  • Schwartz AV, Chen H, Ambrosius WT, Sood A, Josse RG, Bonds DE, Schnall AM, Vittinghoff E, Bauer DC, Banerji MA, Cohen RM, Hamilton BP, Isakova T, Sellmeyer DE, Simmons DL, Shibli-Rahhal A, Williamson JD, Margolis KL. Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study. J Clin Endocrinol Metab. 2015 Nov;100(11):4059-66.
  • Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2015 Jul 16;373(3):232-42.
  • Siddiqi FS, Majumder S, Thai K, Abdalla M, Hu P, Advani SL, White KE, Bowskill BB, Guarna G, Dos Santos CC, Connelly KA, Advani A. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes. J Am Soc Nephrol. 2015 Nov 3.
  • Wang C, Armstrong SM, Sugiyama MG, Tabuchi A, Krauszman A, Kuebler WM, Mullen B, Advani S, Advani A, Lee WL. Influenza-Induced Priming and Leak of Human Lung Microvascular Endothelium upon Exposure to Staphylococcus aureus. Am J Respir Cell Mol Biol. 2015 Oct;53(4):459-70.
  • Connelly KA, Advani A, Zhang Y, Advani SL, Kabir G, Abadeh A, Desjardins JF, Mitchell M, Thai K, Gilbert RE. Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α. J Diabetes. 2015 Jan 7.